Wang GN - Search Results

1

Oral absorption and excretion of icaritin, an aglycone and also active metabolite of prenylflavonoids from the Chinese medicine Herba Epimedii in rats.

Chang Q, Wang GN, Li Y, Zhang L, You C, Zheng Y. Chang Q, et al. Among authors: wang gn. Phytomedicine. 2012 Aug 15;19(11):1024-8. doi: 10.1016/j.phymed.2012.05.017. Epub 2012 Jul 2. Phytomedicine. 2012. PMID: 22762938

2

An LC-MS/MS method for determination of forsythiaside in rat plasma and application to a pharmacokinetic study.

Wang GN, Pan RL, Liao YH, Chen Y, Tang JT, Chang Q. Wang GN, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jan 1;878(1):102-6. doi: 10.1016/j.jchromb.2009.11.029. J Chromatogr B Analyt Technol Biomed Life Sci. 2010. PMID: 19945919

3

A strategy for the improvement of the bioavailability and antiosteoporosis activity of BCS IV flavonoid glycosides through the formulation of their lipophilic aglycone into nanocrystals.

Li Y, Sun S, Chang Q, Zhang L, Wang G, Chen W, Miao X, Zheng Y. Li Y, et al. Mol Pharm. 2013 Jul 1;10(7):2534-42. doi: 10.1021/mp300688t. Epub 2013 May 24. Mol Pharm. 2013. PMID: 23659498

4

An LC-MS/MS method for determination of 3,6'-disinapoylsucrose in rat plasma and its application to a pharmacokinetic study.

Chen Y, Liu XM, Pan RL, Wang GN, Fu Y, Chang Q. Chen Y, et al. Among authors: wang gn. Biomed Chromatogr. 2009 Dec;23(12):1326-32. doi: 10.1002/bmc.1257. Biomed Chromatogr. 2009. PMID: 19517426

5

Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid.

Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB, Wang YT, Tong HH, Zheng Y. Xi J, et al. Among authors: wang yt, wang gn. AAPS PharmSciTech. 2009;10(1):172-82. doi: 10.1208/s12249-009-9190-9. Epub 2009 Feb 18. AAPS PharmSciTech. 2009. PMID: 19224372 Free PMC article.

6

Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.

Tong HH, Du Z, Wang GN, Chan HM, Chang Q, Lai LC, Chow AH, Zheng Y. Tong HH, et al. Among authors: wang gn. Int J Pharm. 2011 Feb 14;404(1-2):148-58. doi: 10.1016/j.ijpharm.2010.11.027. Epub 2010 Nov 19. Int J Pharm. 2011. PMID: 21094233

7

Effects of nitric oxide on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.

Chi OZ, Chang Q, Wang G, Weiss HR. Chi OZ, et al. Anesth Analg. 1997 Feb;84(2):370-5. doi: 10.1097/00000539-199702000-00024. Anesth Analg. 1997. PMID: 9024031

8

Effects of isoproterenol on blood-brain barrier permeability in rats.

Chi OZ, Wang G, Chang Q, Weiss HR. Chi OZ, et al. Neurol Res. 1998 Apr;20(3):259-64. doi: 10.1080/01616412.1998.11740516. Neurol Res. 1998. PMID: 9583589

9

A nonNMDA antagonist, GYKI 52466 improves microscopic O2 balance in the cortex during focal cerebral ischemia.

Chi OZ, Chang Q, Wang G, Liu X, Weiss HR. Chi OZ, et al. Neurol Res. 1999 Apr;21(3):299-304. doi: 10.1080/01616412.1999.11740935. Neurol Res. 1999. PMID: 10319340

10

First-principles study on the adsorption and sensing properties of methyl acetate on VTe₂ doped systems (Ti, Sc, Ru, Y).

Wang GN, Zhang H. Wang GN, et al. Phys Chem Chem Phys. 2024 Dec 11;26(48):29825-29833. doi: 10.1039/d4cp03497j. Phys Chem Chem Phys. 2024. PMID: 39606879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters